In line with these findings, we show that lncRNA-MUF induction by TGF-β is completely abrogated upon treatment with TGFβR1/smad 2/3 inhibitor SB505124 in glioma cells (Figure 2C). This evidence concerns the gene TGFBR1 and central nervous system cancer.